Multidisciplinary approach to implementing ferric carboxymaltose for IV iron replacement in heart failure with iron deficiency
{{output}}
Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF). Treatment with intravenous (IV) iron is recommended by the ACC/AHA/HFSA and ESC guidelines to improve HF symptoms, exercise capacity, and quality of life, and to reduce the risk ... ...
